98%
921
2 minutes
20
This study investigates the use of machine learning (ML) techniques to predict intervention response in patients with Multiple Sclerosis (PwMS) using real-world data from wearable devices. Data from 27 PwMS, monitored over two months were analyzed with several state-of-the-art ML models to predict the efficacy of a computerized cognitive intervention targeting cognitive decline. A model based on Support Vector Machines achieved high accuracy in identifying patient response within the first 2-3 weeks of intervention, aided by feature selection methods like Mutual Information and Recursive Feature Elimination. Early prediction capability enables timely therapeutic adjustments, enhancing personalization of treatment and improving patient quality of life.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.3233/SHTI250603 | DOI Listing |
BioDrugs
September 2025
Department of Nephrology, Instituto de Investigación Hospital "12 de Octubre" (imas12), Avda. De Córdoba s/n, 28041, Madrid, Spain.
Anti-CD20 monoclonal antibodies are gaining clinical relevance in the nephrology community due to their demonstrated efficacy and favorable safety profiles across short-, medium-, and long-term use. Initially developed for hematologic malignancies and multiple sclerosis, B-cell depletion therapies are now being investigated across a broader spectrum of autoimmune diseases, including glomerulopathies, both with and without associated podocytopathy. Recent advances have led to the development of novel anti-CD20 agents that are being used not only as potential alternatives to corticosteroids but also as adjunctive therapies in complex clinical settings.
View Article and Find Full Text PDFJ Neurol
September 2025
College of Physical Education, China West Normal University, Nanchong, China.
Objective: This study aimed to evaluate the effects of various physical therapy interventions on fatigue and quality of life in patients with multiple sclerosis (MS) using a network meta-analysis of randomized controlled trials (RCTs).
Methods: A comprehensive literature search was conducted in PubMed, Web of Science, and Cochrane databases through April 1, 2025. Eligible RCTs compared different exercise interventions in MS patients, focusing on fatigue and quality of life outcomes.
J Virol
September 2025
Department of Biological Sciences, Indian Institute of Science Education and Research Kolkata, Mohanpur, West Bengal, India.
High morbidity and mortality associated with human β-coronavirus (CoV) infection highlight the need to determine host responses to infection and develop anti-viral therapies. Gap junction intercellular communication (GJIC), particularly involving Connexin43 (Cx43), is vital for maintaining central nervous system (CNS) homeostasis, and disruption of GJIC is a well-documented pathogenic mechanism among β-coronaviruses. Specifically, murine β-coronavirus, mouse hepatitis virus (MHV-A59) inoculation in the mouse brain causes acute-stage CNS viral spread and chronic neuroinflammatory demyelination while causing pronounced downregulation of Cx43 at the acute stage, reflecting a critical role in CNS pathology.
View Article and Find Full Text PDFAnn Neurol
September 2025
Weill Institute for Neurosciences, Department of Neurology, University of California San Francisco, San Francisco, CA.
Objective: The objective of this study was to compare the long-term safety profiles of ocrelizumab and rituximab in persons with multiple sclerosis (MS).
Methods: Using retrospective data from the University of California (UC) Health System, we simulated a target clinical trial. The primary cohort from UC San Francisco (UCSF) and a validation cohort from 5 other UC Medical Centers were analyzed.
Brain
September 2025
Neurology Department, Civil Hospital of Guadalajara, 44280 Guadalajara, Jalisco, Mexico.